145 related articles for article (PubMed ID: 37138400)
21. Predictive value of nodal metastases on local recurrence in the management of differentiated thyroid cancer. Retrospective clinical study.
Conzo G; Docimo G; Pasquali D; Mauriello C; Gambardella C; Esposito D; Tartaglia E; Della Pietra C; Napolitano S; Rizzuto A; Santini L
BMC Surg; 2013; 13 Suppl 2(Suppl 2):S3. PubMed ID: 24267409
[TBL] [Abstract][Full Text] [Related]
22. Recurrent Papillary Thyroid Carcinoma to the Cervical Lymph Nodes: Outcomes of Compartment-Oriented Lymph Node Resection.
Rivera-Robledo CG; Velázquez-Fernández D; Pantoja JP; Sierra M; Pérez-Enriquez B; Rivera-Moscoso R; Chapa M; Herrera MF
World J Surg; 2019 Nov; 43(11):2842-2849. PubMed ID: 31372725
[TBL] [Abstract][Full Text] [Related]
23. Optimizing treatment for children and adolescents with papillary thyroid carcinoma in post-Chernobyl exposed region: The roles of lymph node dissections in the central and lateral neck compartments.
Fridman M; Krasko O; Lam AK
Eur J Surg Oncol; 2018 Jun; 44(6):733-743. PubMed ID: 29397264
[TBL] [Abstract][Full Text] [Related]
24. Number of lymph nodes removed during modified radical neck dissection for papillary thyroid cancer does not influence lateral neck recurrence.
Albuja-Cruz MB; Thorson CM; Allan BJ; Lew JI; Rodgers SE
Surgery; 2012 Dec; 152(6):1177-83. PubMed ID: 23040712
[TBL] [Abstract][Full Text] [Related]
25. Nodal Factors Predictive of Recurrence After Thyroidectomy and Neck Dissection for Papillary Thyroid Carcinoma.
Nam SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2018 Jan; 28(1):88-95. PubMed ID: 29117854
[TBL] [Abstract][Full Text] [Related]
26. Lymph Node Dissection for Papillary Thyroid Carcinoma.
Lo CY
Methods Mol Biol; 2022; 2534():57-78. PubMed ID: 35670968
[TBL] [Abstract][Full Text] [Related]
27. Identifying risk factors of recurrence for clinically node negative papillary thyroid carcinoma with pathologic N1a.
Ryu YJ; Cho JS; Park MH; Yoon JH
BMC Surg; 2019 Jul; 19(1):78. PubMed ID: 31277631
[TBL] [Abstract][Full Text] [Related]
28. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma.
Raffaelli M; De Crea C; Sessa L; Tempera SE; Belluzzi A; Lombardi CP; Bellantone R
Endocrine; 2019 Feb; 63(2):310-315. PubMed ID: 30341706
[TBL] [Abstract][Full Text] [Related]
30. Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1-2 Central Lymph Node Metastases.
Wang Y; Deng C; Shu X; Yu P; Wang H; Su X; Tan J
Front Endocrinol (Lausanne); 2021; 12():716728. PubMed ID: 34721289
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic characteristics and outcomes of papillary thyroid carcinoma in younger patients.
Lu Y; Jiang L; Chen C; Chen H; Yao Q
Medicine (Baltimore); 2020 Apr; 99(15):e19795. PubMed ID: 32282744
[TBL] [Abstract][Full Text] [Related]
32. Indications of Superselective Neck Dissection in Patients With Lateral Node Metastasis of Papillary Thyroid Carcinoma.
Song Y; Xu G; Wang T; Zhang Y; Zhang B
Otolaryngol Head Neck Surg; 2022 May; 166(5):832-839. PubMed ID: 34488520
[TBL] [Abstract][Full Text] [Related]
33. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
34. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.
Zhang Q; Wang Z; Meng X; Duh QY; Chen G
Asian J Surg; 2019 Apr; 42(4):571-576. PubMed ID: 30348606
[TBL] [Abstract][Full Text] [Related]
35. Long-term Outcomes of cN0 Papillary Thyroid Carcinoma without Elective Central Compartment Neck Dissection.
Zhou B; Huang H; Xu Z; Wu Y; Wang X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Jun; 39(3):383-388. PubMed ID: 28695810
[TBL] [Abstract][Full Text] [Related]
36. Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.
Rubinstein JC; Dinauer C; Herrick-Reynolds K; Morotti R; Callender GG; Christison-Lagay ER
J Pediatr Surg; 2019 Jan; 54(1):129-132. PubMed ID: 30361076
[TBL] [Abstract][Full Text] [Related]
37. Predictive factors and pattern of central lymph node metastasis in unilateral papillary thyroid carcinoma.
Ji YB; Yoo HS; Song CM; Park CW; Lee CB; Tae K
Auris Nasus Larynx; 2016 Feb; 43(1):79-83. PubMed ID: 26441368
[TBL] [Abstract][Full Text] [Related]
38. Analysis of factors influencing cervical lymph node metastasis of papillary thyroid carcinoma at each lateral level.
Liu WQ; Yang JY; Wang XH; Cai W; Li F
BMC Surg; 2022 Jun; 22(1):228. PubMed ID: 35701785
[TBL] [Abstract][Full Text] [Related]
39. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
40. The localization of thyroid cancers on the thyroid gland is a new risk factor for metastases of perithyroidal, peritracheal and central lymph nodes.
Ocak ÖK; Ergenc H; Ergenc Z; Gökosmanoğlu F
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4017-4022. PubMed ID: 35357577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]